The pharmaceutical industry in the United States is experiencing a substantial surge in requirement for Tirzepatide APIs. This potent medication, used to treat type 2 diabetes, has captured remarkable attention from both consumers and healthcare professionals. As a result, numerous manufacturers have emerged as producers of Tirzepatide APIs in the